We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Issues Guidance on Marketing Biologics in No-Deal Brexit
MHRA Issues Guidance on Marketing Biologics in No-Deal Brexit
The MHRA’s National Institute for Biological Standards and Control (NIBSC) released guidance in anticipation of a no-deal Brexit on March 29, including a flow chart biologic drugmakers can use to determine if their batches require UK certification.